|A case of transfusion‐transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food‐borne route|
K Matsubayashi, JH Kang, H Sakata, K Takahashi, M Shindo, M Kato, ...
Transfusion 48 (7), 1368-1375, 2008
|Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events|
K Otomo, T Atsumi, O Amengual, Y Fujieda, M Kato, K Oku, T Horita, ...
Arthritis & Rheumatism 64 (2), 504-512, 2012
|Dual role of autophagy in stress‐induced cell death in rheumatoid arthritis synovial fibroblasts|
M Kato, C Ospelt, RE Gay, S Gay, K Klein
Arthritis & rheumatology 66 (1), 40-48, 2014
|Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in hepatitis B surface antigen-negative cases|
M Kato, T Atsumi, T Kurita, T Odani, Y Fujieda, K Otomo, T Horita, ...
The Journal of rheumatology, jrheum. 110289, 2011
|Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndrome|
Y Fujieda, T Atsumi, O Amengual, T Odani, K Otomo, M Kato, K Oku, ...
Lupus 21 (14), 1506-1514, 2012
|Demographic, epidemiological, and virological characteristics of hepatitis E virus infections in Japan based on 254 human cases collected nationwide|
T Abe, T Aikawa, Y Akahane, M Arai, Y Asahina, Y Atarashi, K Chayama, ...
Acta Hepatologica Japonica 47 (8), 384-391, 2006
|The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review|
M Kato, H Kataoka, T Odani, Y Fujieda, K Otomo, K Oku, T Horita, ...
Lupus 20 (10), 1047-1056, 2011
|Complement and thrombosis in the antiphospholipid syndrome|
K Oku, H Nakamura, M Kono, K Ohmura, M Kato, T Bohgaki, T Horita, ...
Autoimmunity reviews 15 (10), 1001-1004, 2016
|Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus|
Y Fujieda, H Kataoka, T Odani, K Otomo, M Kato, S Fukaya, K Oku, ...
Modern rheumatology 21 (3), 276-281, 2011
|Long-term outcome in Japanese patients with lupus nephritis|
M Kono, S Yasuda, M Kato, Y Kanetsuka, T Kurita, Y Fujieda, K Otomo, ...
Lupus 23 (11), 1124-1132, 2014
|Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with …|
Y Shimizu, S Yasuda, Y Kako, S Nakagawa, M Kanda, R Hisada, ...
Autoimmunity reviews 15 (8), 786-794, 2016
|Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin‐6 production in rheumatoid arthritis synovial fibroblasts|
B Aradi, M Kato, M Filkova, E Karouzakis, K Klein, M Scharl, C Kolling, ...
Arthritis & Rheumatology 67 (10), 2624-2633, 2015
|Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study|
R Hisada, M Kato, E Sugawara, Y Fujieda, K Oku, T Bohgaki, O Amengual, ...
Journal of Thrombosis and Haemostasis 15 (9), 1782-1787, 2017
|Significance of fully automated tests for the diagnosis of antiphospholipid syndrome|
K Oku, O Amengual, M Kato, T Bohgaki, T Horita, S Yasuda, N Sakamoto, ...
Thrombosis research 146, 1-6, 2016
|The involvement of CD36 in monocyte activation by antiphospholipid antibodies|
M Kato, T Atsumi, K Oku, O Amengual, H Nakagawa, Y Fujieda, K Otomo, ...
Lupus 22 (8), 761-771, 2013
|A mini-outbreak of HEV infection in those who enjoyed Yakiniku party: one died of fulminant hepatitis|
Kanzo 45, 688, 2004
|First‐Line, Non‐Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti–β2‐Glycoprotein I Domain …|
H Nakamura, K Oku, O Amengual, K Ohmura, Y Fujieda, M Kato, ...
Arthritis care & research 70 (4), 627-634, 2018
|Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention|
M Kato, T Atsumi
Rheumatology international 36 (5), 635-641, 2016
|Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC)|
K Oku, T Atsumi, Y Akiyama, H Amano, N Azuma, T Bohgaki, YF Asanuma, ...
Modern rheumatology 28 (4), 642-648, 2018
|Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies|
O Amengual, T Horita, W Binder, GL Norman, Z Shums, M Kato, K Otomo, ...
Rheumatology international 34 (9), 1225-1230, 2014